91 related articles for article (PubMed ID: 23252896)
1. Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17.
Gradolatto A; Nazzal D; Foti M; Bismuth J; Truffault F; Le Panse R; Berrih-Aknin S
Ann N Y Acad Sci; 2012 Dec; 1274():40-7. PubMed ID: 23252896
[TBL] [Abstract][Full Text] [Related]
2. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.
Gradolatto A; Nazzal D; Truffault F; Bismuth J; Fadel E; Foti M; Berrih-Aknin S
J Autoimmun; 2014 Aug; 52():53-63. PubMed ID: 24405842
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia.
Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S
Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672
[TBL] [Abstract][Full Text] [Related]
5. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis.
Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S
Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863
[TBL] [Abstract][Full Text] [Related]
6. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
Aricha R; Mizrachi K; Fuchs S; Souroujon MC
J Autoimmun; 2011 Mar; 36(2):135-41. PubMed ID: 21193288
[TBL] [Abstract][Full Text] [Related]
7. CD4+ CD25(high) regulatory T cell in childhood ocular myasthenia gravis.
Sakuma H; Katayama A; Saito Y; Komaki H; Nakagawa E; Sugai K; Sasaki M
Brain Dev; 2011 May; 33(5):442-4. PubMed ID: 20797828
[TBL] [Abstract][Full Text] [Related]
8. Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis.
Villegas JA; Bayer AC; Ider K; Bismuth J; Truffault F; Roussin R; Santelmo N; Le Panse R; Berrih-Aknin S; Dragin N
J Autoimmun; 2019 Mar; 98():59-73. PubMed ID: 30578016
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.
Souroujon MC; Aricha R; Feferman T; Mizrachi K; Reuveni D; Fuchs S
Ann N Y Acad Sci; 2012 Dec; 1274():120-6. PubMed ID: 23252906
[TBL] [Abstract][Full Text] [Related]
10. Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects.
Truffault F; Nazzal D; Verdier J; Gradolatto A; Fadel E; Roussin R; Eymard B; Le Panse R; Berrih-Aknin S
Front Immunol; 2020; 11():782. PubMed ID: 32435245
[TBL] [Abstract][Full Text] [Related]
11. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
12. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
Zhang J; Zhou WB; Wang HL; Guo SS
Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
[TBL] [Abstract][Full Text] [Related]
13. The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics.
Alahgholi-Hajibehzad M; Kasapoglu P; Jafari R; Rezaei N
Expert Rev Clin Immunol; 2015; 11(7):859-70. PubMed ID: 25973691
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune mechanisms in myasthenia gravis.
Cavalcante P; Bernasconi P; Mantegazza R
Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
[TBL] [Abstract][Full Text] [Related]
15. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
Zhang Y; Wang HB; Chi LJ; Wang WZ
Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
[TBL] [Abstract][Full Text] [Related]
16. An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients.
Villegas JA; Van Wassenhove J; Le Panse R; Berrih-Aknin S; Dragin N
Ann N Y Acad Sci; 2018 Feb; 1413(1):154-162. PubMed ID: 29405352
[TBL] [Abstract][Full Text] [Related]
17. Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells.
Aricha R; Feferman T; Berrih-Aknin S; Fuchs S; Souroujon MC
Ann N Y Acad Sci; 2012 Dec; 1275():107-13. PubMed ID: 23278585
[TBL] [Abstract][Full Text] [Related]
18. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
[TBL] [Abstract][Full Text] [Related]
19. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
Itoh M; Takahashi T; Sakaguchi N; Kuniyasu Y; Shimizu J; Otsuka F; Sakaguchi S
J Immunol; 1999 May; 162(9):5317-26. PubMed ID: 10228007
[TBL] [Abstract][Full Text] [Related]
20. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
